Corvus Pharmaceuticals, Inc. (CRVS)
NASDAQ: CRVS · Real-Time Price · USD
7.66
+0.07 (0.92%)
Oct 29, 2025, 3:33 PM EDT - Market open
Corvus Pharmaceuticals Analyst Ratings
Total Analysts
4
Consensus Rating
Strong Buy
Price Target
$13.75
Upside
+79.50%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Barclays | Barclays | Buy Initiates $16 | Buy | Initiates | $16 | +108.88% | Oct 13, 2025 |
| Mizuho | Mizuho | Buy Maintains $12 → $11 | Buy | Maintains | $12 → $11 | +43.60% | May 20, 2025 |
| Oppenheimer | Oppenheimer | Buy Reiterates $15 → $17 | Buy | Reiterates | $15 → $17 | +121.93% | May 9, 2025 |
| Oppenheimer | Oppenheimer | Buy Maintains $14 → $15 | Buy | Maintains | $14 → $15 | +95.82% | Mar 26, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $11 | Strong Buy | Reiterates | $11 | +43.60% | Mar 26, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $11 | Strong Buy | Reiterates | $11 | +43.60% | Jan 14, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $11 | Strong Buy | Initiates | $11 | +43.60% | Jan 2, 2025 |
| Oppenheimer | Oppenheimer | Buy Reiterates $8 → $14 | Buy | Reiterates | $8 → $14 | +82.77% | Nov 13, 2024 |
| Mizuho | Mizuho | Hold → Buy Upgrades $3.5 → $12 | Hold → Buy | Upgrades | $3.5 → $12 | +56.66% | Oct 22, 2024 |
| Ladenburg Thalmann | Ladenburg Thalmann | Strong Buy Maintains $12 → $21 | Strong Buy | Maintains | $12 → $21 | +174.15% | Sep 16, 2024 |
| Oppenheimer | Oppenheimer | Buy Maintains $7 → $8 | Buy | Maintains | $7 → $8 | +4.44% | May 7, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates n/a | Buy | Reiterates | n/a | n/a | Apr 1, 2024 |
| Mizuho | Mizuho | Hold Maintains $3.5 | Hold | Maintains | $3.5 | -54.31% | Mar 27, 2024 |
| Oppenheimer | Oppenheimer | Buy Maintains $8 → $7 | Buy | Maintains | $8 → $7 | -8.62% | Mar 20, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $4 | Buy | Reiterates | $4 | -47.78% | Sep 7, 2023 |
| Mizuho | Mizuho | Hold Reiterates $3.5 | Hold | Reiterates | $3.5 | -54.31% | Jun 16, 2023 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.